Highlighted research, Published January 22, 2024
Using ELISpot to evaluate personalized RNA neoantigen vaccines in pancreatic cancer
Explore how Mabtech’s ELISpot Pro: Human IFN-γ, kits contributed to cutting-edge cancer vaccine research, as demonstrated in a recent study on personalized RNA neoantigen vaccines in pancreatic cancer.